Phase Ib Study of Axatilimab in Combination With Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Incyte Corporation
Related studies linked through entity extraction aliases.
Extension Study to Provide Continued Treatment for Patients With Hematologic Malignancies Previously Enrolled in Studies With Tafasitamab
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Evaluate the Effect of Povorcitinib on the QT/QTc Interval in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Phase I/II Trial of Pemigatinib in Combination With Atezolizumab and Bevacizumab for Treatment of Advanced Cholangiocarcinoma With FGFR2 Fusion
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Assess the Effect of Povorcitinib on Digoxin, Rosuvastatin, and Metformin Pharmacokinetics and the Effect of Probenecid on Povorcitinib Pharmacokinetics When Administered Orally to Healthy Adult Participants
- Status
- COMPLETED
- Phase
- PHASE1
Topical Ruxolitinib Evaluation in Immune-related Lichenoid Skin-Toxicities
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study to Evaluate the Drug Interaction Between Povorcitinib and the Oral Contraceptive Levonorgestrel/Ethinyl Estradiol in Healthy Adult Females
- Status
- COMPLETED
- Phase
- PHASE1
High Dose Ruxolitinib and Allogeneic Stem Cell Transplantation in Myelofibrosis Patients With Splenomegaly
- Status
- RECRUITING
- Phase
- PHASE2
Pre-Transplant INCBB099280 for Hepatocellular Carcinoma (HCC)
- Status
- WITHDRAWN
- Phase
- PHASE1
Axatilimab in Combination With Retifanlimab and Paclitaxel for the Treatment of Patients With Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Evaluate the Safety, Tolerability of INCB160058 in Participants With Myeloproliferative Neoplasms
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study to Evaluate the Relative Bioavailability of Ruxolitinib Extended Release (XR) Tablets Compared With Ruxolitinib Immediate Release (IR) Tablets Administered Orally in Healthy Participants.
- Status
- COMPLETED
- Phase
- PHASE1
A Study Assessing the Mass Balance, Pharmacokinetics, and Metabolite Profiles of a Single Oral Dose of [14C]INCB099280 in Healthy Male Participants
- Status
- COMPLETED
- Phase
- PHASE1
Pemigatinib + Afatinib in Advanced Refractory Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Pemigatinib in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphomas
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxolitinib Cream During Pregnancy With an Unexposed Control Population
- Status
- RECRUITING
- Phase
- N/A
A Study to Evaluate the Efficacy, and Safety Study of Ruxolitinib Cream in Adults With Moderate Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE3
Ruxolitinib Plus Fostamatinib for Steroid Refractory cGvHD
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Evaluate the Safety and Tolerability of Maximal Use Ruxolitinib Cream
- Status
- COMPLETED
- Phase
- PHASE1